Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery

The blood–brain barrier (BBB) is pivotal in maintaining neuronal physiology within the brain. This review delves into the alterations of the BBB specifically in the context of geriatric epilepsy. We examine how age-related changes in the BBB contribute to the pathogenesis of epilepsy in the elderly...

Full description

Bibliographic Details
Main Authors: Xin Chen, Juan Luo, Min Song, Liang Pan, Zhichuang Qu, Bo Huang, Sixun Yu, Haifeng Shu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1342366/full
_version_ 1827355914787618816
author Xin Chen
Juan Luo
Juan Luo
Min Song
Liang Pan
Zhichuang Qu
Bo Huang
Sixun Yu
Haifeng Shu
Haifeng Shu
author_facet Xin Chen
Juan Luo
Juan Luo
Min Song
Liang Pan
Zhichuang Qu
Bo Huang
Sixun Yu
Haifeng Shu
Haifeng Shu
author_sort Xin Chen
collection DOAJ
description The blood–brain barrier (BBB) is pivotal in maintaining neuronal physiology within the brain. This review delves into the alterations of the BBB specifically in the context of geriatric epilepsy. We examine how age-related changes in the BBB contribute to the pathogenesis of epilepsy in the elderly and present significant challenges in pharmacotherapy. Subsequently, we evaluate recent advancements in drug delivery methods targeting the BBB, as well as alternative approaches that could bypass the BBB’s restrictive nature. We particularly highlight the use of neurotropic viruses and various synthetic nanoparticles that have been investigated for delivering a range of antiepileptic drugs. Additionally, the advantage and limitation of these diverse delivery methods are discussed. Finally, we analyze the potential efficacy of different drug delivery approaches in the treatment of geriatric epilepsy, aiming to provide insights into more effective management of this condition in the elderly population.
first_indexed 2024-03-08T04:50:14Z
format Article
id doaj.art-f8254463596e489dbffb547d61d60fd1
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-03-08T04:50:14Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-f8254463596e489dbffb547d61d60fd12024-02-08T05:18:51ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652024-02-011610.3389/fnagi.2024.13423661342366Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug deliveryXin Chen0Juan Luo1Juan Luo2Min Song3Liang Pan4Zhichuang Qu5Bo Huang6Sixun Yu7Haifeng Shu8Haifeng Shu9Department of Neurosurgery, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaDepartment of Neurosurgery, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Pediatrics, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, Meishan City People's Hospital, Meishan, Sichuan, ChinaDepartment of Burn and Plastic, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, Western Theater General Hospital, Chengdu, Sichuan, ChinaDepartment of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, ChinaThe blood–brain barrier (BBB) is pivotal in maintaining neuronal physiology within the brain. This review delves into the alterations of the BBB specifically in the context of geriatric epilepsy. We examine how age-related changes in the BBB contribute to the pathogenesis of epilepsy in the elderly and present significant challenges in pharmacotherapy. Subsequently, we evaluate recent advancements in drug delivery methods targeting the BBB, as well as alternative approaches that could bypass the BBB’s restrictive nature. We particularly highlight the use of neurotropic viruses and various synthetic nanoparticles that have been investigated for delivering a range of antiepileptic drugs. Additionally, the advantage and limitation of these diverse delivery methods are discussed. Finally, we analyze the potential efficacy of different drug delivery approaches in the treatment of geriatric epilepsy, aiming to provide insights into more effective management of this condition in the elderly population.https://www.frontiersin.org/articles/10.3389/fnagi.2024.1342366/fullblood–brain barriergeriatric epilepsyantiepileptic therapyantiepileptic drugnanoparticle
spellingShingle Xin Chen
Juan Luo
Juan Luo
Min Song
Liang Pan
Zhichuang Qu
Bo Huang
Sixun Yu
Haifeng Shu
Haifeng Shu
Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
Frontiers in Aging Neuroscience
blood–brain barrier
geriatric epilepsy
antiepileptic therapy
antiepileptic drug
nanoparticle
title Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
title_full Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
title_fullStr Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
title_full_unstemmed Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
title_short Challenges and prospects in geriatric epilepsy treatment: the role of the blood–brain barrier in pharmacotherapy and drug delivery
title_sort challenges and prospects in geriatric epilepsy treatment the role of the blood brain barrier in pharmacotherapy and drug delivery
topic blood–brain barrier
geriatric epilepsy
antiepileptic therapy
antiepileptic drug
nanoparticle
url https://www.frontiersin.org/articles/10.3389/fnagi.2024.1342366/full
work_keys_str_mv AT xinchen challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT juanluo challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT juanluo challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT minsong challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT liangpan challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT zhichuangqu challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT bohuang challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT sixunyu challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT haifengshu challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery
AT haifengshu challengesandprospectsingeriatricepilepsytreatmenttheroleofthebloodbrainbarrierinpharmacotherapyanddrugdelivery